Currently holds positions in Catalyst Biosciences Inc, Globeimmune Inc, Human Genome Sciences Inc and Cardiovascular Systems Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Catalyst Biosciences Inc | Feb. 15, 2018 - |
Independent Director | Globeimmune Inc | June 1, 2003 - |
Independent Director | Human Genome Sciences Inc | March 3, 2004 - |
Independent Director | Cardiovascular Systems Inc | Feb. 1, 2009 - |
Independent Director | Catalyst Biosciences Inc | Aug. 20, 2015 - Feb. 15, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2020-02-25 | 2020-02-25 |
Catalyst Biosciences Inc
(CBIO)
|
S Sale |
69,401
-100.0%
6.10423,506 USD |
69,401 -100.0% | 6.10 | 423,506 USD | |
2019-02-05 | 2019-02-05 |
Leap Therapeutics Inc
(LPTX)
|
B Purchase |
571,428
+16.1%
1.75999,999 USD |
571,428 +16.1% | 1.75 | 999,999 USD | |
2017-11-16 | 2017-11-14 |
Leap Therapeutics Inc
(LPTX)
|
B Purchase |
1,057,769
+42.0%
6.096,436,524 USD |
1,057,769 +42.0% | 6.09 | 6,436,524 USD |